PATRONIZERS
SPONSORS
SCIENTIFIC COMMITTEE
Prof. Lina Ghibelli; Prof. Albrecht Reichle, MD; Dr. Giulia Piaggio; Prof.
Eugenio Martinelli; Prof. Enrico Traversa;
Dr. Daniel Heudobler, MD; Dr. Pan Pantziarka; Prof. Christopher Gerner; Dr.
Emanuele Bruni; Dr. Francesca Corsi
CONFIRMED KEYNOTE LECTURES:Yuval Shaked, Marc Diederich, Bozena Kaminska, Danny Dhanasekaran, Monika Schäfer- Korting, Francesco Cecconi, Fabrizio D’Adda di Fagagna
REGISTRATION NOW OPEN at:
www.anakoinosis.org
Meeting starts: May 13th, 14:00 Meeting ends: May 15th, 16:30
Third International Conference on
ANAKOINOSIS
AN INNOVATIVE ANTICANCER THERAPY TARGETING THE ABERRANT CANCER TISSUE HOMEOSTASIS
- a novel and long lasting opportunity for sustainable drug development-
Chairs: Lina Ghibelli, Albrecht Reichle
Rome
Villa Mondragone, May 13th-15th, 2020
The Conference is linked with a Research Topic of “Frontiers in Pharmacology” where speakers may contribute with a review or data paper
https://www.frontiersin.org/research-topics/12957 WHAT ANAKOINOSIS IS
Anakoinosis, from the Grecian Anakoinosis (communication), is a paradigmatic new anticancer therapy aimed at correcting aberrant tissue cancer homeostasis by re-activating lost tissue and systemic defences. Going beyond the classical genetic view of cancer, it takes into account the cell-to-cell communication to restore the health of target cancer tissue. Originally designed for palliative care, anakoinosis showed unexpected anticancer potential.
WHAT TO EXPECT FROM THIS CONFERENCE
We want to build a “repository” of the still scattered observations implying that tissues obey laws that go beyond the strict gene- or cell-autonomous regulatory circuitry. This repository would be a coherent structural framework on Molecular Tissue Dynamics in Cancer Microenvironment. These data may pave the road for to identify/produce new biomodulatory compounds that eliminate/control tumor cells by correcting the aberrant cancer homeostasis.
WHO SHOULD PARTICIPATE
To promote the opportunity for a sustainable development of new-concept anticancer drug, we solicit participation of Researchers in areas of clinical oncology, translational studies, basic cell/tissue biology research, regenerative medicine, theoretical modelling, systems biology, innovative technological tools, pharmacology, and drug design.
MAIN TOPICS
• ANAKOINOSIS CLINICAL STRATEGIES AND CLINICAL TOOLS
• BIOLOGICAL BASES OF ANAKOINOSIS
• MOLECULAR TISSUE DYNAMICS
• NOVEL TECHNIQUES AND STRATEGIES TO STUDY ANAKOINOSIS
• ANAKOINOSIS, A NOVEL OPPORTUNITY FOR SUSTAINABLE DRUG DEVELOPMENT
www.anakoinosis.org
CONTACT: anakoinosis@libero.it
09/02/2020, 13)21 VILLA MONDRAGONE
Page 1 of 2 https://www.romasposa.it/component/spsimpleportfolio/item/180-villa-mondragone
! info@romasposa.it (mailto:info@romasposa.it)
! (https://www.facebook.com/RomaSposa.official/) " (https://www.instagram.com/romasposa.official/)
# (https://www.youtube.com/channel/UCDlE95sNtID-wu979T8EM6w/videos)
HOME (/) ABOUT (/ABOUT) LOCATION (/LOCATION)$ BIGLIETTI
ESPOSITORIGALLERY (/GALLERY) PRESS (/RASSEGNA-STAMPA) VILLA MONDRAGONE
"Indietro
Via Consalvi snc – 00044 Frascati RM Tel. 06 9309919 venere@glieventi.it www.glieventi.it (http://www.glieventi.it/) Facebook: @villa Mondragone (https://www.facebook.com/villamondragoneroma/) (/)
09/02/2020, 12(41 pianta-om-grafica.jpg 1.509×998 pixels
Page 1 of 1 http://www.villamondragone.it/wp-content/uploads/2016/02/pianta-om-grafica.jpg
